My father had macular degeneration for the last few years of his 83-year life.

FORBES: Avastin vs Lucentis: One Step Closer to Cost Rationing?

At a recent conference I attended with my wife, who is a retinal surgeon, I witnessed a debate over two treatments for macular degeneration that illustrates the problems.

FORBES: Wrong Incentives in Medicare Waste Billions